Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma in Hepatitis C Virus Infected Patients”

7 trials

Showing 7 of 7 results

Not applicableUnknownNCT03247296
What this trial is testing

Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir

Who this might be right for
Hepatitis C
MTI University 200
Not applicableStudy completedNCT02785835
What this trial is testing

Hepatocellular Carcinoma in HIV-infected Patients

Who this might be right for
Hepatocellular CarcinomaHIVChronic Hepatitis C+2 more
Hospital Universitario de Valme 477
Not applicableStudy completedNCT03707080
What this trial is testing

Direct Acting Antiviral-Post Authorization Safety Study

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Target PharmaSolutions, Inc. 42
Not applicableStudy completedNCT01355107
What this trial is testing

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

Who this might be right for
Hepatitis CLiver CirrhosisCarcinoma, Hepatocellular
University Hospital Freiburg 32
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Testing effectiveness (Phase 2)Study completedNCT01022476
What this trial is testing

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

Who this might be right for
HIV InfectionLiver FailureEvidence of Liver Transplantation
ANRS, Emerging Infectious Diseases 14
Not applicableUnknownNCT01729221
What this trial is testing

Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.

Who this might be right for
Hepatocellular Carcinoma in Hepatitis C Virus Infected Patients
Cairo University 280

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation